Evidence map›Paper›PMID 41428712›Full record

ArticleJournal of visualized experiments : JoVE2025

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro.

Sofia V Krylova, Daniel Zamith-Miranda, Alus M Xiaoli, Xiaofan Yu, Joshua D Nosanchuk, Fajun Yang, Jeffrey E Pessin, Daorong Feng

Abstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sofia V KrylovaDepartment of Medicine, Albert Einstein College of Medicine; Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine; Department of Molecular Pharmacology, Albert Einstein College of Medicine.
Daniel Zamith-MirandaDepartment of Microbiology and Immunology, Albert Einstein College of Medicine; Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine.
Alus M XiaoliDepartment of Medicine, Albert Einstein College of Medicine; Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine.
Xiaofan YuDepartment of Medicine, Albert Einstein College of Medicine; Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine.
Joshua D NosanchukDepartment of Microbiology and Immunology, Albert Einstein College of Medicine; Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine.
Fajun YangDepartment of Medicine, Albert Einstein College of Medicine; Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine; Department of Developmental and Molecular Biology, Albert Einstein College of Medicine.
Jeffrey E PessinDepartment of Medicine, Albert Einstein College of Medicine; Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine; Department of Molecular Pharmacology, Albert Einstein College of Medicine.
Daorong FengDepartment of Medicine, Albert Einstein College of Medicine; Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine; daorong.feng@einsteinmed.edu.

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI Ulrich Steidl · 1985 to 2026
$111.2M
The Mediator complex in the coordinate regulation of lipogenic gene expressionR01DK110063 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ELISCOVICH, CAROLINA INES, PESSIN, JEFFREY E. · 2016 to 2025
$5.9M
Molecular Mechanism of Brown Adipose Tissue RegressionR01DK128839 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI FENG, DAORONG, PESSIN, JEFFREY E. · 2021 to 2024
$2.3M
Novel effectors of insulin action in the liverR01DK117417 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI YANG, FAJUN JAMES · 2020 to 2023
$2.1M
Regulation of adipose tissue remodeling by the CCNC-MediatorR01DK139610 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Fajun James Yang · 2025 to 2026
$1.3M
NCI NIH HHS P30 CA013330NIDDK NIH HHS R01 DK110063NIDDK NIH HHS R01 DK117417NIDDK NIH HHS R01 DK128839NIDDK NIH HHS R01 DK139610
6 · The paper itself

Abstract

Adipocytes are increasingly recognized as active endocrine cells that secrete substantial quantities of EVs enriched in proteins, lipids, and nucleic acids. However, the mechanisms governing EV secretion and the dynamics of EV release in different biological contexts are not fully understood. To address this gap, we generated a novel adipocyte-specific CD63-GFP reporter mouse line, in which expression of GFP-tagged CD63 is driven by the Adiponectin promoter, enabling selective labeling and tracking of AdEVs in vivo. Using this reporter model, we examined secretion of AdEVs and their delivery to APCs within adipose tissues. Confocal imaging and flow cytometry revealed that AdEVs are actively taken up by APCs, highlighting a previously underappreciated mechanism of paracrine communication within the adipose microenvironment. To complement the in vivo studies, an in vitro system was established, allowing for the direct monitoring of EV secretion from differentiated adipocytes. APCs were isolated from subcutaneous white adipose tissues of the reporter mice and induced to differentiate into mature adipocytes. In these cells, CD63-GFP signals were observed as discrete puncta and became enriched at the plasma membrane when EV secretion was inhibited, consistent with vesicle accumulation upon blocked release. Under normal growth conditions, EVs secreted into the culture medium were concentrated and subsequently purified using size exclusion chromatography, enabling downstream functional and biochemical analyses. This platform can be applied to APCs derived from other adipose depots, such as epididymal white and brown adipose tissue, or by differentiating them into depot-specific adipocytes, thereby enabling comparisons of EV secretion among different adipocyte types. Together, these approaches introduce a robust genetic tool and a complementary in vitro system to dissect the dynamics of AdEV secretion and targeting. These advances shed light on intra-adipose cellular communication and lay the groundwork for understanding the broader metabolic influence of AdEVs in health and disease.

Indexed as

AdipocytesExtracellular VesiclesGreen Fluorescent ProteinsTetraspanin 30AnimalsGenes, ReporterMaleMiceMice, TransgenicCd63 protein, mouseGreen Fluorescent ProteinsTetraspanin 30

Identifiers

PMID41428712
PMCPMC13002251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.